NDC 51662-1564-03 - ZIPRASIDONE MESYLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1564
- Requested NDC
- 51662-1564-03
- Package NDCs from labels
- 51662-1564-2, 51662-1564-3, 51662-1564-03
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZIPRASIDONE MESYLATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1564-2 | ZIPRASIDONE MESYLATE | 1 in 1 POUCH | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 | |
| 51662-1564-2 | ZIPRASIDONE MESYLATE | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 5 | 2 | |
| 51662-1564-3 | ZIPRASIDONE MESYLATE | 10 in 1 CASE | INJECTION, POWDER, LYOPHILIZED, | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1564 | ZIPRASIDONE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240201_c75971f8-9640-a6e8-e053-2995a90af654.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 1ffd16c3-25ac-4839-9ea9-4efd32926b95 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Novadoz Pharmaceuticals LLC | 90b35a26-ab65-4c39-b97f-55c8c0e34b0b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | b28a4f3d-0aae-050d-e053-2995a90aa4a6 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | 90f55022-8d58-4bfb-9464-9bf11395ae17 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Gland Pharma Limited | 77a10f48-e300-465f-81b5-54be38daa4b3 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ZIPRASIDONE MESYLATE | ZIPRASIDONE MESYLATE | HF Acquisition Co LLC, DBA HealthFirst | c75971f8-9640-a6e8-e053-2995a90af654 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 51662-1564-2 51662-1564-3 51662-1564 51662156403 351223 1035b793-4301-3cb4-e063-6294a90a5b1f c75971f8-9640-a6e8-e053-2995a90af654 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 3cb79985-1207-602e-2dda-a118133b4c60 | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 43598-848 351223 44d8fcde-2e03-b6e8-d5dd-d062e075be8c 3cb79985-1207-602e-2dda-a118133b4c60 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 6fd6fc45-20c4-e223-3532-ce37aa02b71c | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.